14
149980.KQ Hironic Co. Ltd
- Market cap
- KRW 66.1B
- P/E
- 14.7x
- P/B
- 0.84x
- ROE
- 5.2%
- Dividend yield
- 6.06%
- Fundamental score
- 1.3/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 149980.KQ undervalued?
Graham number149980.KQ trades 26.2% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hironic Co. Ltd fundamental analysis
7 of 22 checks passedROE 0/2
Low return on equity (5.2%), below 10%.
ROA 0/1
Return on assets (4.6%) is below the industry median (6.2%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (151.7%) is above the 5-year average (-3.4% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (151.7%) is above the industry median (0.5%).
Revenue Growth 1/2
Revenue grew 5.2% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 120.4x against interest expense, well covered.
PE vs Market 0/1
PE (14.7x) is above the market median (11.3x).
PE vs Industry 0/1
PE (14.7x) is above the industry median (7.6x).
PBV 0/1
Price to book (0.8x) is above the industry median (0.7x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 12.3, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Hironic Co. Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hironic Co. Ltd
Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.
Full company profileHironic Co. Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hironic Co. Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 15.5B | 18.1B | 20.3B | 20.1B | 13.0B | 21.8B | 27.6B | 33.7B | 31.6B | 32.1B | 40.8B |
| Gross Profit | 9.94B | 11.9B | 11.9B | 12.0B | 8.07B | 13.2B | 14.9B | 19.2B | 12.2B | 18.9B | 26.3B |
| Operating Income | 347M | 1.75B | -28.4M | 2.61B | 1.24B | 4.63B | 3.58B | 5.27B | -6.35B | 4.11B | 5.11B |
| EBITDA | - | - | - | - | - | - | 5.80B | 11.2B | -7.11B | 6.01B | 7.71B |
| Net Income | 719M | 763M | -260M | 2.90B | 3.18B | 6.78B | 2.93B | 8.22B | -7.05B | 3.16B | 4.10B |
| EPS | 54 | 59 | -21 | 231 | 258 | 499 | 216 | 489 | -419 | 216 | 238 |
| Balance Sheet | |||||||||||
| Total Assets | 44.7B | 50.0B | 43.0B | 46.9B | 44.8B | 63.7B | 67.5B | 79.1B | 78.4B | 71.2B | 88.3B |
| Total Liabilities | 1.92B | 10.1B | 5.26B | 6.14B | 3.16B | 7.72B | 8.84B | 6.69B | 10.2B | 7.71B | 9.21B |
| Shareholders' Equity | 42.8B | 39.9B | 37.8B | 40.7B | 41.6B | 55.9B | 58.7B | 72.3B | 68.2B | 63.5B | 79.0B |
| Cash & Short-term Investments | 23.0B | 17.0B | 13.5B | 17.1B | 18.3B | 20.7B | 24.4B | 6.03B | 2.83B | 2.96B | 11.3B |
| Total Debt | - | - | - | 1.48B | - | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 501M | 1.44B | -1.52B | 4.29B | 4.11B | 427M | 4.50B | -1.14B | 5.52B | -88.1M | 905M |
| Capital Expenditure | 3.22B | 1.08B | 1.79B | 660M | 341M | 1.57B | 547M | 878M | 1.87B | 2.36B | 681M |
| Free Cash Flow | - | - | - | - | 3.67B | -1.26B | 3.69B | -2.02B | 3.64B | -2.45B | 224M |
| Ratios | |||||||||||
| ROE | 1.7% | 1.9% | -0.7% | 7.1% | 7.6% | 12.1% | 5.0% | 11.4% | -10.3% | 5.0% | 5.2% |
| ROA | 1.6% | 1.5% | -0.6% | 6.2% | 7.1% | 10.6% | 4.3% | 10.4% | -9.0% | 4.4% | 4.6% |
| Net Profit Margin | 4.6% | 4.2% | -1.3% | 14.4% | 24.5% | 31.1% | 10.6% | 24.4% | -22.3% | 9.8% | 10.1% |
| Debt to Equity | - | - | - | 0.04x | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hironic Co. Ltd dividends
- Dividend yield
- 6.06%
- Forward dividend
- 233.00 KRW
- Payout ratio
- -
- Ex-dividend date
- Jun 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | KRW 604M | 45 | 8.9% |
| 2020 | KRW 704M | 57 | 22.2% |
| 2019 | KRW 37.7M | 3.00 | 1.3% |
| 2018 | KRW 38.8M | 3.09 | - |
| 2017 | KRW 134M | 10 | 17.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.2:1 on Feb 7, 2024.
Who owns Hironic Co. Ltd
- Insiders 61.06%
- Institutions 0.10%
- Public & others 38.84%
- Shares outstanding 17.2M
- Free float 6.65M
Hironic Co. Ltd company profile
- Company name
- Hironic Co. Ltd
- Ticker
- 149980.KQ
- ISIN
- KR7149980005
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- December
- Address
- U-Tower, Yongin-Si, South Korea, 16827
- Phone
- 82 3 1525 7000
- Website
- hironic.com
About Hironic Co. Ltd
Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.
Hironic Co. Ltd management
1- Kwang Park SeokChief Executive Officer